Publications and Presentations Database

Sort by: [ Author (Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Roberts, J. S. (2003).  The REVEAL Study: Genetic testing for sporadic Alzheimer’s disease.
Roberts, J. S. (2016).  Ethical considerations in the implementation of precision medicine.
Roberts, J. S., Blow, F. C., Copeland, L. A., Barry, K. L., & Van Stone, W. (2000).  Age-group differences in treatment outcomes for male veterans with severe schizophrenia: a three-year longitudinal study. Journal of geriatric psychiatry and neurology. 13(2), 78-86. Abstract
Roberts, J. S. (2015).  Giving patients incidental information from genomic sequencing.
Roberts, J. S. (2015).  A conversation on the genomic revolution / evolution.
Roberts, J. S., & Tersegno, S. M. (2010).  Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions.. Future neurology. 5(4), 501-517. Abstract
Roberts, J. S. (2011).  Health education and genetic counseling for individuals with mild cognitive impairment.
Roberts, J. S., LaRusse, S. A., Katzen, H., Whitehouse, P. J., Barber, M., Post, S. G., et al. (2003).  Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease. Alzheimer disease and associated disorders. 17(2), 86-93. Abstract
Roberts, J. S. (2007).  Understanding the process and impact of genetic susceptibility testing for Alzheimer’s disease.
Roberts, J. S., & et al (2008).  Psychological and behavioral impact of a condensed protocol for disclosing APOE genotype and risk information for Alzheimer’s disease: The REVEAL Study.
Roberts, J. S. (2013).  Using biomarkers to disclose risk information for Alzheimer's disease: Ethical and psychosocial implications.
Roberts, J. S., & et al (2006).  Age group differences in response to genetic risk assessment for Alzheimer’s disease.
Roberts, J. S., Green, R. C., Relkin, N., Whitehouse, P., Brown, T., Barber, M., et al. (2002).  Genetic susceptibility testing for adult children of patients with Alzheimer’s disease: Participants’ self-reports on the impact of risk assessment.
Roberts, J. S. (2005).  Racial and ethnic differences in perceptions of dementia.
Roberts, J. S. (2017).  Opportunities and challenges in precision oncology.
Roberts, J. S. (2015).  How might genomic sequencing impact parents and children? .
Roberts, J. S. (2012).  Genetic risk assessment for Alzheimer’s disease.
Roberts, J. S. (2008).  Development of an interactive website to provide tailored education & risk communication to women at high risk of breast cancer.
Roberts, J. S. (2009).  The ethical implications of genetic susceptibility testing for individuals at risk for Alzheimer’s disease.
Roberts, J. S., Chen, C. A., Uhlmann, W. R., & Green, R. C. (2012).  Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease. Genetics in medicine : official journal of the American College of Medical Genetics. 14(8), 742-8. Abstract
Roberts, J. S., & et al (2007).  Age group differences in response to genetic risk assessment for Alzheimer’s disease.
Roberts, J. S., Green, R. C., Nelkin, N., Whitehouse, P., Brown, T., Barber, M., et al. (2003).  How do participants rate the impact of genetic susceptibility testing for Alzheimer’s disease?.
Roberts, J. S. (2005).  Genetic susceptibility testing for Alzheimer’s disease.
Roberts, J. S. (2017).  Disclosing genetic and neuroimaging risk information in the new era of Alzheimer's prevention trials: Practical and ethical challenges and opportunities.
Roberts, J. S. (2012).  More than senior moments: Understanding early signs of memory changes.